PLoS ONE (Jan 2021)

Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease.

  • Ying Zhuang Ng,
  • Lee Lee Lai,
  • Sui Weng Wong,
  • Siti Yatimah Mohamad,
  • Kee Huat Chuah,
  • Wah Kheong Chan

DOI
https://doi.org/10.1371/journal.pone.0250300
Journal volume & issue
Vol. 16, no. 5
p. e0250300

Abstract

Read online

Background & aimWe studied FibroTouch (FT) and Fibroscan (FS) examination results and their repeatability when performed by healthcare personnel of different background.MethodsFT and FS examinations were performed on patients with chronic liver disease by two operators, a doctor and a nurse, twice on each patient, at two different time points, independent of each other.ResultsThe data for 163 patients with 1304 examinations was analyzed. There was strong correlation between FT and FS for attenuation parameter (Spearman's rho 0.76, pConclusionMeasurements obtained with FT and FS strongly correlated, but significant differences in their absolute values, consistency, examination time and number of invalid measurements were observed. Either device can be used by healthcare personnel of different backgrounds when sufficiently trained.